ROSEMARIE BATISTE: Open Payments
NPI 1245434851 · NAPERVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,172 in 38 payments from 20 companies in 2025. Trend: 2023 $928 · 2024 $748 · 2025 $1,172
Food & beverage: $1,172
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $234 |
| Ipsen Biopharmaceuticals, Inc | 1 | $140 |
| Novartis Pharmaceuticals Corporation | 5 | $99 |
| Merck Sharp & Dohme LLC | 4 | $86 |
| Lilly USA, LLC | 3 | $76 |
| Janssen Biotech, Inc. | 3 | $76 |
| Genentech USA, Inc. | 3 | $75 |
| ABBVIE INC. | 2 | $55 |
| PFIZER INC. | 2 | $50 |
| Gilead Sciences, Inc. | 2 | $42 |
Products named: Onivyde, ENHERTU, DATROWAY, KEYTRUDA, Tecentriq, VERZENIO, KISQALI, RYBREVANT.
Industry payments across IL — which companies pay providers there.
